Phase (Ph) II Bevacizumab + Erlotinib for Patients (Pts) With Recurrent Malignant Glioma (MG)

Clinical trial NCT00671970 · COMPLETED

Trial details

NCT number: NCT00671970
Sponsor: Duke University
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Glioblastoma Gliosarcoma

Start date: 2007-02-01
Primary completion: 2008-11-01
Enrollment: 57

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.